Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 24947
Evènement :SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017

Dates :Lundi 22 Mai 2017 - Mardi 23 Mai 2017

Lieu :Copthorne Tara Hotel
Scarsdale Place, Kensington
W8 5SY London, Royaume-Uni

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs).

With this continued development, SMi has been receptive to the steadily increasing market growth and have launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place 22nd – 23rd May in London, UK.

The conference programme has been produced to enable delegates to gain knowledgeable insight on how to develop highly potent APIs more efficiently, safely and more cost effectively than before. Whether your area of expertise is in process development, scale up, occupational safety or outsourcing, this two day conference is certain to equip you with a wealth of actionable insights.  

FEATURED SPEAKERS:
Alessandro Brigo, Toxicology Project Leader, Pharmaceutical Sciences
Andreas Flueckiger, Chief Occupational Health Officer, Roche
Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca
Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Hungary
Jack Brown, Senior Principal Scientist, Boehringer Ingelheim
James Evans, Vice President CMC, NuCana BioMed
Jason Hamm, Director of Chemical Development Operations, Bristol-Myers Squibb
Richard Denk, Head Sales Containment, SKAN AG

CONFERENCE HIGHLIGHTS
Address the challenges of working with HPAPIs and approaches to scale-up
Discuss strategies for CMO selection and solutions to better communication and transfer
Hear about Teva API’s Operational Excellence and QC Lab Transformation
Gain insight into the ISPE contamination Manual covering containment issues from the PDE/ OEL to life cycle
Learn about Health Hazard Assessment Classifications and the toxicological criteria of potent compounds

 

Time: 8:30 am - 5:30 pm

URLs:

Website: https://go.evvnt.com/80100-0
Inquiries: https://go.evvnt.com/80100-1

Price:
Register by 31 Jan: GBP 1099
Register by 28 Feb: GBP 1299
Register by 31 Mar: GBP 1399
Standard Price: GBP 1499

Speakers: Pharmaceutical Sciences, Roche, AstraZeneca, Gedeon Richter Hungary, Boehringer Ingelheim, NuCana BioMed, Bristol-Myers Squibb, SKAN AG and many more!

Lieu

Plan et itinéraire
Adresse de la conférence :
Copthorne Tara Hotel
Scarsdale Place, Kensington
W8 5SY London
Royaume-Uni
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017 Pharmacie
api- active pharmaceutical ingredients, cytoxic, potency, ha - health agency, pde - permitted daily exposure, cross contamination, compound, scale up
Tout public
-- -- --
--

Divers

Pour plus d'informations sur SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017, veuillez contacter SMi Group

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement